Starpharma company secretary retires this week
Starpharma (ASX:SPL) has announced the imminent retirement of long-serving company secretary Ben Rogers.
Rogers will be replaced on Friday by Starpharma CFO Nigel Baade, who has been with the company for seven years.
Starpharma CEO Dr Jackie Fairley said Rogers and Baade have been working together closely for the past seven years, meaning the transition should be painless.
“As an executive team we have worked closely with Ben over many years and the executive and the board thank him for his valuable contribution,” Fairley said. “We are fortunate to have had a natural choice in Nigel to succeed Ben in the position of Company Secretary.”
In September, Starpharma revealed it was developing a new dendrimer-enhanced chemotherapy drug, dendrimer oxaliplatin. The company’s first dendrimer-enhanced chemotherapy, dendrimer docetaxel, is at the phase I trial stage.
Starpharma (ASX:SPL) shares were trading 2.26% lower at $0.777 as of around 1 pm on Tuesday.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
